Liège, Belgium, February 14, 2022 – 5:45 p.m. CET – In accordance with article 15 of the law of May 2, 2007 relating to the disclosure of significant holdings in issuers whose shares are admitted to trading on a regulated market and relating miscellaneous provisions, Mithra Pharmaceuticals SA (“the Company” or “Mithra”) publishes the following information, following the issue of 442,191 new shares today for a total amount of 8,061,142 euros following the notification of put option issued on December 20211 under LDA Capital’s commitment agreement.